Menu
At Moehs Fine Chemicals, our primary focus is on producing high-quality pharmaceutical active ingredients. With over 50 years of experience, we’re renowned for our expertise in manufacturing APIs and providing Custom Manufacturing services to the pharmaceutical industry. Operating in more than 90 countries globally, we boast a state-of-the-art research center dedicated to synthesis, analysis, regulatory affairs, toxicology, and IP development. Our commitment to safety, environmental responsibility, and quality is evident in all our products and services. Our recent highlights include our participation in industry projects, patent acquisitions, and the appointment of a new CEO. As a leading player in the pharmaceutical active ingredients market, we continuously strive to exceed expectations and drive innovation in the industry.
| Product Name CAS No | Therapeutic Category | Standard Package | Regulatory Data | Pharma- copoeias | Production Site |
|---|---|---|---|---|---|
| ACEBUTOLOL HCl (34381-68-5) | Antianginal- Antihypertensive- Antiarrhythmic | Fiber drum, 40 Kg | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | CANTABRA & COPRIMA |
| ACEBUTOLOL HCI (34381-68-5) | Antiviral - Antiparkinsonian | Fiber drum, 40 Kg | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | CATALANA |
| AMANTADINE HCI (665-66-7) | Antiviral - Antiparkinsonian | Fiber drum, 25 Kg | EDMF | DAC 2011 | CANTABRA |
| ARTICAINE HCl or CARTICAINE HCl (23964-57-0) | Antianginal - Antihypertensive | Fiber drum, 50 Kg | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, | BENECHIM |
| BISOPROLOL FUMARATE (104344-23-2) | Antihypertensive | Fiber drum, 25 Kg | CEP, EDMF USDMF JDMF, ND | Ph. Eur. 11 USP-NF-2022, JP 16 | CATALANA |
| BUPIVACAINE HCl (73360-54-0) | Local Anesthetic- Antiarrhythmic | Fiber drum, 25 kg | CEP, EDMF USDMF, ND | Ph. Eur. 11 USP-NF-2022 | CATALANA |
| CARBOCYSTEINE (638-23-3) | Mucolytic | Fiber drum, 50 Kg | CEP, EDMF JDMF | Ph. Eur. 11 JP 16 | CATALANA & BCN |
| CARVEDILOL (72956-09-3) | Antihypertensive | Fiber drum, 25 Kg | CEP, EDMF USDMF, JDMF KDMF, ND | Ph. Eur. 11 USP-NF-2022 | CATALANA & COPRIMA |
| CARBOCYSTEINE LYSINE SALT (151756-26-2) | Mucolytic | Fiber drum, 50 Kg | EDMF | In house | BCN |
| CELIPROLOL HCl (57470-78-7) | Antianginal- Antihypertensive | Fiber drum, 25 Kg | CEP, EDMF JDMF | Ph. Eur. 11 | COPRIMA |
| CHOLINE FENOFIBRATE (856676-23-8) | Antihyperlipidemic | Fiber drum, 50 Kg | USDMF | In house | COPRIMA |
| DEXMEDETOMIDINE HCl (145108-58-3) | Sedative | Fiber drum | DMF | USP-NF-2022 | NORCHIM & IBERICA |
| DULOXETINE HCl (136434-34-9) | Antidepressant | Fiber drum, 30 Kg | CEP, EDMF USDMF, KDMF | Ph. Eur. 11 USP-NF-2022 | CANTABRA & BCN |
| FENOFIBRATE (49562-28-9) | Antihyperlipidemic | Fiber drum 50 Kg | CEP, EDMF USDMF, ND | Ph. Eur. 11 USP-NF-2022 | COPRIMA |
| LIDOCAINE BASE (137-58-06) | Local Anesthetic- Antiarrhythm | Fiber drum, 50 Kg | CEP, EDMF JDMF, USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | CATALANA & BCN |
| LIDOCAINE HCl (6108-05-0) | Local Anesthetic- Antiarrhythm | Fiber drum, 35 Kg | CEP, EDMF JDMF, USDMF | Ph. Eur. 11 USP-NF-2022, | CATALANA & BCN |
| MAGNESIUM LACTATE DIHYDRATE (18917-93-6) | Magnesium Supplement | Fiber drum, 50 Kg | EDMF, ND | Ph. Eur. 11 | CANTABRA |
| MEBEVERINE HCl (2753-45-9) | Antispasmodic | Fiber drum, 30 Kg | EDMF, ND | Ph. Eur. 12 BP 2013 | BENECHIM |
| MEPIVACAINE HCl (1722-62-9) | Local Anesthetic- Antiarrhythmic | Fiber drum, 20 Kg | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | CATALANA |
| METOPROLOL SUCCINATE (98418-47-4) | Antihypertensive | Fiber drum, 25 Kg | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022 | CATALANA & BENECHIM |
| METOPROLOL TARTRATE (56392-17-7) | Antihypertensive | Fiber drum, 25 Kg | CEP, EDMF USDMF, JDMF | CEP, EDMF USDMF, JDMF | CATALANA |
| N-ACETYLCYSTEINE (616-91-1) | Mucolytic | Fiber drum, 50 Kg | CEP, EDMF USDMF, ND | Ph. Eur. 11 USP-NF-2022 | CATALANA |
| NIFEDIPINE (21829-25-4) | Antianginal- Antihypertensive | Fiber drum, 50 Kg | CEP, EDMF USDMF, JDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | CATALANA |
| NIFUROXAZIDE (965-52-6) | Antidiarrheal | Fiber drum, 40 Kg | EDMF, ND | Ph. Eur. 11 | COPRIMA |
| PANTOPRAZOLE SODIUM (164579-32-2) | Antiulcerative | Fiber drum, 25 Kg | CEP, EDMF USDMF, ND | Ph. Eur. 11 USP-NF-2022 | CANTABRA |
| PRILOCAINE BASE (721-50-6) | Local Anesthetic | Fiber drum, 25Kg | EDMF, USDMF | Ph. Eur. 11 USP-NF-2022 | BENECHIM |
| PRILOCAINE HCl (1786-81-8) | Local Anesthetic- Antiarrhythm | Fiber drum, 25Kg | EDMF, USDMF | Ph. Eur. 11 USP-NF-2022 | BENECHIM |
| PYRANTEL EMBONATE (22204-24-6) | Anthelmintic | Fiber drum, 20Kg | EVMF USVMF | Ph. Eur. 11 USP-NF-2022, JP 16 | CATALANA & COPRIMA |
| QUETIAPINE FUMARATE (111974-72-2) | Antipsychotic | Fiber drum, 25Kg | CEP, EDMF USDMF, KDMF | Ph. Eur. 11 USP-NF-2022 | CANTABRA |
| RABEPRAZOLE SODIUM (117976-90-6) | Antiulcerative | Fiber drum, 25Kg | CEP, EDMF USDMF, ND | Ph. Eur. 11 | CATALANA |
| ROPIVACAINE HCl (132112-35-7) | Local Anesthetic | Fiber drum, 25Kg | USDMF | Ph. Eur. 11 USP-NF-2022 | BENECHIM |
| SITAGLIPTIN HCI (862156-92-1) | Antidiabetic | Fiber drum, 50 Kg | EDMF | In house | BENECHIM |
| SOTALOL HCI (959-24-0) | Antianginal- Antihypertensive | Fiber drum, 30 Kg | CEP, EDMF USDMF, ND | Ph. Eur. 11 USP-NF-2022 | CATALANA |
| SUMATRIPTAN BASE 103628-46-2) | Antimigraine | Fiber drum /Kg | USDMF | USP-NF-2022 | CATALANA |
| SUMATRIPTAN SUCCINATE (103628-48-4) | Antimigraine | Fiber drum /Kg | EDMF, USDMF, JDMF | Ph. Eur. 11 USP-NF-2022 | CATALANA |
| TRIAMTERENE (396-01-0) | Diuretic | Fiber drum 35 Kg | CEP, EDMF USDMF, JDMF | Ph. Eur. 11 USP-NF-2022, JP 16 | CATALANA |
| TRIMEBUTINE BASE (39133-31-8) | Antispasmodic | Fiber drum 30 Kg | EDMF | In house | CANTABRA |
| TRIMEBUTINE MALEATE (34140-59-5) | Antispasmodic | Fiber drum 50 Kg | CEP, EDMF ND | Ph. Eur. 11 JP 16 | CATALANA & CANTABRA |
| VENLAFAXINE HCI (99300-78-4) | Antidepressant | Fiber drum 25 Kg | CEP, EDMF USDMF | Ph. Eur. 11 USP-NF-2022 | CANTABRA |
| VILDAGLIPTIN (274901-16-5) | Antidiabetic | Fiber drum 50 Kg | DMF | Ph. Eur. 11 | BCN |
| Product Name CAS No | Therapeutic Category | Status | Regulatory Data | Pharmacopoeias |
|---|---|---|---|---|
EDOXABAN TOSYLATE (**) (1229194-11-9) | Oral anticoagulant | Validation batches | DMF | |
| EMPAGLIFLOZIN (**) (864070-44-0) | Antidiabetic | Validation batches | DMF | |
| LEVOBUPIVACAINE HCI (27262-48-2) | Local Anesthetic- Antiarrhythmic | Validation batches | DMF | |
| NORADRENALINE TARTRATE (108341-18-0) | Cardiovascular | Validation batches | TP | USP / Ph. Eur. |
| RIMEGEPANT SULFATE (**) (1374024-48-2) | Acute migraine | Validation batches | DMF | |
| RIVAROXABAN (**) (366789-02-8) | Oral anticoagulant | Validation batches | DMF | Ph. Eur. |
| SITAGLIPTIN PHOSPHATE (**) (654671-77-9) | Antidiabetic | Validation batches | DMF | USP / Ph. Eur. |
(**) Products covered by valid patents are being developed under experimental aims in base of Art. 10(6)
of Directive 2004/27/EC, exclusively directed to obtain market authorizations of our customers’ generic medicines.
Samples for R&D use in the United States are available as permitted under 35 USC § 271 (e) (1).
Products covered by valid patents in any country are not offered or supplied to these countries when such offer constitutes a
patent infringement.
| Product Name CAS No | Therapeutic Category | Status |
|---|---|---|
| ABROCITINIB (**) (1622902-68-4) | Atopic Dermatitis | Laboratory batches |
| DARIDOREXANT (**) (1792993-84-0) | Insomnia | Laboratory batches |
| DEUCRAVACITINIB (**) (1609392-27-9) | Psoriasis | Laboratory batches |
| ELAGOLIX SODIUM (**) (832720-36-2) | Uterine Fibroids, Endometriosis pain | Validation batches |
| LASMIDITAN SUCCINATE (**) (439239-92-6) | Antimigraine | Kilo-lab batches |
| LEMBOREXANT (**) (1369764-02-2) | Insomnia | Laboratory batches |
| LINZAGOLIX (**) (935283-04-8) | Uterine Fibroids, Endometriosis | Laboratory batches |
| "MAVACAMTEN (**) (1642288-47-8)" | Hypertrophic Cardiomyopathy | Kilo-lab batches |
| RELUGOLIX (**) (737789-87-6) | Advanced prostate cancer Uterine Fibroids, endometriosis | Kilo-lab batches |
| REMIMAZOLAM BESYLATE (**) (308242-62-8) | Sedation General Anesthesia | Validation batches |
| TIRBANIBULIN (**) (897016-82-9) | Actinic Keratosis | Kilo-lab batches |
| VERICIGUAT (**) (1350653-20-1) | Heart Failure | Kilo-lab batches |
| FEZOLINETANT (**) (1629229-37-3) | Menopausal Vasomotor symptoms | Laboratory batches |
| ZAVEGEPANT (**) (1414976-20-7) | Acute migraine | Laboratory batches |
(**) Products covered by valid patents are being developed under experimental aims in base of Art. 10(6)
of Directive 2004/27/EC, exclusively directed to obtain market authorizations of our customers’ generic medicines.
Samples for R&D use in the United States are available as permitted under 35 USC § 271 (e) (1).
Products covered by valid patents in any country are not offered or supplied to these countries when such offer constitutes a
patent infringement.
| Product Name CAS No | Brand Name | Therapeutic Category | Galenic Form |
|---|---|---|---|
| BEXAGLIFLOZIN (**) (1118567-05-7) | Bexacat / Brenzavvy | Diabetes mellitus | Oral |
| BLARCAMESINE (**) (195615-83-9 ) | - | Alzheimer Rett Syndrome | Oral |
| ETRASIMOD (**) (1206123-37-6) | Velsipity | Ulcerative colitis | Oral |
| ELACESTRANT (**) (722533-56-4) | Orserdu | Breast cancer | Oral |
| ELINZANETANT (**) (929046-33-3) | - | Vasomotor symptoms of Menopause | Oral |
| ENSIFENTRINE (**) (1884461-72-6 / 298680-25-8) | - | Chronic obstructive pulmonary disease | Inhalation |
| GEPIRONE (**) (83928-66-9) | Exxua | Major depressive disorders | Oral |
| TAPINAROF (**) (115781-08-3) | Vtama | Psoriasis | Topic |
(**) Products covered by valid patents are being developed under experimental aims in base of Art. 10(6)
of Directive 2004/27/EC, exclusively directed to obtain market authorizations of our customers’ generic medicines.
Samples for R&D use in the United States are available as permitted under 35 USC § 271 (e) (1).
Products covered by valid patents in any country are not offered or supplied to these countries when such offer constitutes a
patent infringement.